Sanovas’ PulmoVia Snags FDA 510(k) Clearance

Sanovas’ PulmoVia Working Channel for use during pulmonary interventions has won FDA 510(k) clearance, the San Rafael, Calif., devicemaker announced Friday.

The single-use device is engineered to improve diagnostic and therapeutic lung treatment, the company says.

The PulmoVia allows delivery of a large-diameter operating channel through a small-diameter optic, which doubles the amount of space available in the lungs.

As such, medical professionals can use bigger instruments to obtain tissue samples, retrieve foreign bodies and begin therapy while critical care patients are still able to breathe effectively. — Jason Scott